Koers Standard BioTools Inc.
Aandelen
LAB
US34385P1084
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,42 USD | -5,47% | -10,70% | +9,50% |
Omzet 2024 * | 201 mln. 188 mln. | Omzet 2025 * | 232 mln. 217 mln. | Marktkapitalisatie | 979 mln. 915 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -161 mln. -151 mln. | Nettowinst (verlies) 2025 * | -69 mln. -64,51 mln. | EV/omzet 2024 * | 4,87 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,22 x |
K/w-verhouding 2024 * |
-5,95
x | K/w-verhouding 2025 * |
-14,2
x | Werknemers | 537 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,94% |
Recentste transcriptie over Standard BioTools Inc.
1 dag | -5,47% | ||
1 week | -10,70% | ||
Lopende maand | -10,70% | ||
1 maand | -9,70% | ||
3 maanden | +1,26% | ||
6 maanden | +14,69% | ||
Lopend jaar | +9,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 04-04-22 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 15-05-23 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | 05/01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 01-04-22 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 15-03-23 |
Kathy Hibbs
BRD | Director/Board Member | 60 | 05/01 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 2,42 | -5,47% | 2 331 908 |
23-04-24 | 2,56 | +0,79% | 2 265 813 |
22-04-24 | 2,54 | +0,79% | 2 286 002 |
19-04-24 | 2,52 | -0,79% | 2 753 470 |
18-04-24 | 2,54 | -2,68% | 2 831 907 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,50% | 979 mln. | |
+8,78% | 219 mld. | |
+8,24% | 187 mld. | |
+11,16% | 134 mld. | |
+26,12% | 101 mld. | |
+0,30% | 62,27 mld. | |
+16,21% | 52,82 mld. | |
-1,63% | 47,49 mld. | |
-1,11% | 40,79 mld. | |
+12,16% | 39,35 mld. |